in_the_media
Psychiatric Meds: Perils, Promises, and Profits
Posted Oct 23, 2011
Media Outlet:
Chronicle of Higher Education
In a letter to the editor, Frank Farley, a professor in Temple's College of Education, worries that the increasing number of disorders being identified in the psychiatric field can be expected to cause a rise in new medications being developed and prescribed to treat them: "The diagnostic growth industry represented by the Diagnostic and Statistical Manual of the American Psychiatric Association increasingly pathologizes human behavior, expanding by more than 200 percent the number of disorders from the original DSM of 1952 to the current fourth edition — a process we can reasonably call 'the sickening of society.'"